October 01, 2014 2:10 PM ET

Biotechnology

Company Overview of CPEX Pharmaceuticals, Inc.

Company Overview

CPEX Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, licensing, and commercialization of pharmaceutical products utilizing its drug delivery platform technology. The company offers Testim, a gel for testosterone replacement therapy; Ser-120, a product candidate for the treatment of nocturia; and CPE-215, a drug delivery technology, which is used to enhance the absorption of drugs through the nasal mucosa, skin, and eye. The company sells its CPE-215 product to pharmaceutical and biotechnology companies. CPEX Pharmaceuticals, Inc. was founded in 2007 and is based in Wilmington, Delaware. As of April 5, 2011, CPEX Pharmaceuticals, Inc. was taken private.

2 Holland Way

Exeter, NH 03833

United States

Founded in 2007

13 Employees

Phone:

603-658-6100

Fax:

302-427-4607

Key Executives for CPEX Pharmaceuticals, Inc.

Vice President of Regulatory Affairs
Clinical Consultant
Age: 74
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
ApoVax, Inc. United States
Inhibrx LLC United States
Neumedicines, Inc. United States
Afferent Pharmaceuticals, Inc. United States
Pamlico Biopharma, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CPEX Pharmaceuticals, Inc., please visit www.cpexpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.